EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway

Leyi Yang, Xiaoping Wang, Qinghai Lin, Guoyi Shen, Hong Chen

Journal of Molecular Histology · 2024

DOI: 10.1007/s10735-024-10267-5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Molecular Histology, 2024. Verfasst von Leyi Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Surgery, Zhangzhou Hospital, Fujian Medical University, No 59 Shengli West Road, Xiangcheng district, Zhangzhou, Fujian province…. Hauptthemen laut MEDLINE: Breast Neoplasms, Hedgehog Proteins, Forkhead Box Protein M1, Signal Transduction. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Claudins (CLDNs) play a crucial role in regulating the permeability of epithelial barriers and can impact tumor behavior through alterations in their expression. However, the precise mechanisms underlying the involvement of CLDNs in breast cancer progression remain unclear. This study aimed to investigate the role of CLDN11 in breast cancer progression. Utilizing the TCGA database and clinical specimens from breast cancer patients, we observed reduced expression of CLDN11 in tumor tissues, which correlated with poor prognosis in breast cancer patients. In vitro, silencing of CLDN11 enhanced the proliferative and migratory characteristics of breast cancer cell lines MCF-7 and MDA-MB-231. Mechanistically, CLDN11 deficiency promoted the upregulation of Forkhead Box M1 (FOXM1) by activating the hedgehog signaling pathway, thereby sustaining tumor progression in breast cancer. In vivo, blockade of hedgehog signaling suppressed the tumor progression induced by CLDN11 silencing. Our study highlights the significance of the CLDN11/FOXM1 axis in breast cancer progression, suggesting CLDN11 as a potential diagnostic indicator and therapeutic target for clinical therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsHedgehog ProteinsForkhead Box Protein M1Signal TransductionClaudinsGene Expression Regulation, NeoplasticDisease ProgressionCell ProliferationHumansFemaleCell Line, TumorAnimalsCell MovementUp-RegulationMicePrognosisMCF-7 Cells

Stichwörter der Autor:innen

Breast cancerCLDN11FOXM1Hedgehog signaling

Substanzen

Hedgehog ProteinsForkhead Box Protein M1ClaudinsFOXM1 protein, human

Autor:innen und Institutionen

  • Department of Breast Surgery, Zhangzhou Hospital, Fujian Medical University, No 59 Shengli West Road, Xiangcheng district, Zhangzhou, Fujian province, 363000, China.
  • Department of Breast Surgery, Zhangzhou Hospital, Fujian Medical University, No 59 Shengli West Road, Xiangcheng district, Zhangzhou, Fujian province, 363000, China. LinQinghai24@outlook.com.
  • Department of Thoracic Surgery, Zhangzhou Hospital, Fujian Medical University, Zhangzhou, China.
  • Department of Ultrasound, Zhangzhou Hospital, Fujian Medical University, Zhangzhou, China.

Zitieren

APA

Yang, L., Wang, X., Lin, Q., Shen, G., & Chen, H. (2024). CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway. Journal of Molecular Histology. https://doi.org/10.1007/s10735-024-10267-5

Vancouver

Yang L, Wang X, Lin Q, Shen G, Chen H. CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway. Journal of Molecular Histology. 2024. doi:10.1007/s10735-024-10267-5

BibTeX
@article{Yang2024,
  author = {Yang, Leyi and Wang, Xiaoping and Lin, Qinghai and Shen, Guoyi and Chen, Hong},
  title = {CLDN11 deficiency upregulates FOXM1 to facilitate breast tumor progression through hedgehog signaling pathway},
  journal = {Journal of Molecular Histology},
  year = {2024},
  doi = {10.1007/s10735-024-10267-5}
}
Kostenlos starten →